Today: 17 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

BitMine (BMNR) stock jumps 15% as Tom Lee presses 50‑billion authorized-share vote — what investors watch next

BitMine (BMNR) stock jumps 15% as Tom Lee presses 50‑billion authorized-share vote — what investors watch next

BitMine shares surged 14.9% to $31.19 Friday after the company urged shareholders to approve raising its authorized shares to 50 billion from 500 million. The vote deadline is Jan. 14 ahead of a Jan. 15 meeting. BitMine cited flexibility for stock splits, capital raising, and acquisitions. The stock was little changed after hours.
GE Vernova stock (GEV) rises nearly 4% to kick off 2026 — what traders watch next

GE Vernova stock (GEV) rises nearly 4% to kick off 2026 — what traders watch next

GE Vernova shares rose 3.8% to $679.55 Friday, outperforming the S&P 500 in the first U.S. trading session of 2026. No new company news drove the move; the stock has rallied since December after GE Vernova raised its outlook, expanded buybacks, and doubled its dividend. Investors await U.S. jobs and inflation data next week. The company’s next quarterly results are due later this month.
3 January 2026
Applied Materials stock jumps 4.6% to start 2026 — here’s what could move AMAT next week

Applied Materials stock jumps 4.6% to start 2026 — here’s what could move AMAT next week

Applied Materials shares jumped 4.6% to $268.87 Friday, snapping a two-day slide as chip stocks rallied and the Philadelphia Semiconductor Index rose 4%. Trading volume topped 7.5 million shares, slightly above average. Lam Research and KLA also gained, while ASML surged 8.8% after an analyst upgrade. Investors now await U.S. jobs data Jan. 9 and CPI figures Jan. 13 for rate signals.
3 January 2026
Coinbase stock rises after Brian Armstrong maps 2026 ‘everything exchange’ push

Coinbase stock rises after Brian Armstrong maps 2026 ‘everything exchange’ push

Coinbase shares rose 4.6% to $236.53 Friday after CEO Brian Armstrong outlined a 2026 plan to expand into multi-asset trading, stablecoin payments, and onchain adoption. The update comes as U.S. lawmakers debate new crypto rules and traders await key economic data next week. Bitcoin traded near $89,932 Saturday. Coinbase’s Friday range was $226.03 to $238.47.
Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next

Lam Research stock jumps 8% to start 2026 as chip-tool shares rally — what LRCX investors watch next

Lam Research shares surged 8.1% to $185.06 Friday, leading semiconductor equipment stocks after the U.S. changed licensing rules for chipmaking tool shipments to China. The Philadelphia Semiconductor Index rose about 4%. Investors are watching for further export-rule updates and Lam’s next earnings date, expected in late January or early February.
Mastercard stock slides after New Year kickoff; jobs data and dividend date in focus

Mastercard stock slides after New Year kickoff; jobs data and dividend date in focus

Mastercard shares fell 1.36% to $563.13 on Friday, marking a fourth consecutive decline and closing about 6% below their 52-week high. Trading volume rose above average as Treasury yields climbed and investors reset positions for 2026. The stock underperformed the broader U.S. market, with traders eyeing upcoming economic data, Mastercard’s Jan. 9 dividend record date, and late-January earnings.
3 January 2026
Rocket Lab stock jumps 9% as RKLB traders weigh insider-sale filing and defense-contract backdrop

Rocket Lab stock jumps 9% as RKLB traders weigh insider-sale filing and defense-contract backdrop

Rocket Lab shares rose 8.9% to close at $75.99 Friday after trading between $66.85 and $76.24, with 31.2 million shares exchanged. After the close, an SEC filing showed officer Frank Klein plans to sell up to 100,000 shares. Investors remain focused on Rocket Lab’s $816 million Space Development Agency contract announced in December. The stock was up 0.3% in after-hours trading.
1 443 444 445 446 447 741

Stock Market Today

  • Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models
    April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast, a discounted cash flow (DCF) model values shares at $47.64, signaling overvaluation based on cash flow projections. This valuation split highlights uncertain assumptions about Symbotic's ability to translate its backlog into sustainable cash earnings, with risks including customer concentration and contract delays.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:51 AM EDT India's FX Curbs Raise Hedging Costs, Weigh on Bonds and Equities amid Iran War Risks April 17, 2026, 4:51 AM EDT. **Foreign institutional investors (FIIs)** are growing cautious on India as new **foreign exchange (FX) restrictions** by the Reserve Bank of India (RBI) raise hedging costs for rupee exposure. The RBI's curbs, aimed at limiting arbitrage trades, have driven up one-year hedging costs by around 30 basis points onshore and nearly 70 basis points offshore via non-deliverable forward (NDF) markets, making Indian bonds less attractive.
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop